M&A Deal Summary |
|
|---|---|
| Date | 2003-09-02 |
| Target | COMPASS Services |
| Sector | Healthcare Services |
| Buyer(s) | PharMEDium Healthcare |
| Sellers(s) | Baxter International |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Healthcare Services |
PharMEDium Healthcare Holdings, Inc. is a provider of intravenous (IV) admixture services supplied to the hospital market. The Company’s IV admixture service involves the mixing of drug compounds into intravenous solutions for infusion into patients.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2003 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1931 |
| Sector | Medical Products |
| Employees | 38,000 |
| Revenue | 10.6B USD (2024) |
Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 7 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 6 |
| Country: United States M&A | 1 of 5 |
| Year: 2003 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-10-01 |
Baxter International - Cardiovascular Businesss
Japan Baxter International, Inc. - Cardiovascular Businesss is a manufacturer of medical products for cardio. |
Sell | $22M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-11-06 |
Baxter International - Indibulin
Deerfield, Illinois, United States Baxter International, Inc. - Indibulin is a novel synthetic anti-cancer agent that targets mitosis like the taxanes. |
Sell | - |
